Blog
RSS FeedPosted by Michael Wonder on 02 Sep 2021
FDA reaches milestone in competitive generic therapy drug approvals
2 September 2021 - This week, the FDA reached the milestone of approving more than 100 generic drug applications with a ...
Posted by Michael Wonder on 02 Sep 2021
Natco Pharma (Canada) announces the launch of Nat-Lenalidomide capsules, the first generic alternative to Revlimid
1 September 2021 - Nat-Lenalidomide expands affordable treatment options for patients with multiple myeloma and patients with transfusion-dependent anaemia due to ...
Posted by Michael Wonder on 28 Jul 2021
'New regulation limiting generic drugs will change industrial paradigm'
27 July 2021 - The Korea Pharmaceutical and Bio-pharma Manufacturers Association said the revision of the Pharmaceutical Affairs Act to ...
Posted by Michael Wonder on 23 Jun 2021
TGA approves first generic pomalidomide
23 June 2021 - The TGA has approved first generic version of Celgene's Pomalyst. ...
Posted by Michael Wonder on 22 Jun 2021
Acrux receives approval from the FDA for its generic version of Jublia
22 June 2021 - Acrux is pleased to announce that the US FDA has granted approval of the Company’s generic version ...
Posted by Michael Wonder on 21 Jun 2021
Factors associated with generic drug uptake in the United States, 2012 to 2017
19 June 2021 - In the United States, brand-name prescription drugs remain expensive until market exclusivity ends and lower cost generics ...
Posted by Michael Wonder on 01 Jun 2021
Lannett announces FDA acceptance, as a priority original ANDA, of the generic Advair Diskus filing
1 June 2021 - Lannett today announced the U.S. FDA has accepted the abbreviated new drug application for fluticasone propionate and ...
Posted by Michael Wonder on 31 May 2021
Apotex medicines in New Zealand
31 May 2021 - Apotex has announced that it is leaving the New Zealand market. ...
Posted by Michael Wonder on 27 May 2021
7 out of 10 Koreans want cheaper drug with same ingredient
27 May 2021 - Seven out of 10 Koreans want to lower the drug cost by choosing a cheaper generic ...
Posted by Michael Wonder on 21 May 2021
PHARMAC to work with others to improve communication
21 May 2021 - PHARMAC accepts the Coroner’s comments that not all information about the brand change reached patients. ...
Posted by Michael Wonder on 22 Apr 2021
The TGA claims Tenofovir Emtricitabine Sandoz is a first generic but is it?
22 April 2021 - Closer examination suggests otherwise. ...
Posted by Michael Wonder on 22 Mar 2021
Oakrum Pharma and Aucta Pharma announce U.S. FDA approval of generic version of Jadenu Sprinkle (deferasirox granules)
22 March 2021 - Oakrum Pharma in collaboration with Aucta Pharmaceuticals announced today the U.S. approval of a generic version of ...
Posted by Michael Wonder on 21 Mar 2021
Washington may become the second state to distribute its own generic drugs
17 March 2021 - A bill moving through the Washington legislature may make the state only the second in the ...
Posted by Michael Wonder on 17 Mar 2021
PHARMAC’s drug switch
17 March 2021 - PHARMAC's generic drug swap for epilepsy treatment saved $30 million over five years. But for some ...
Posted by Michael Wonder on 09 Mar 2021
Sun Pharma announces Drizalma Sprinkle (duloxetine delayed release capsules) is now covered by most Medicare Part D plans
9 March 2021 - Coverage for novel formulation of duloxetine now offered to 91% of lives in top 10 Medicare Part ...